← Leaderboards
Dennis E Hallahan
Vanderbilt University
$13,109,924
Attributed
$14,574,891
Total exposure
17
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$14,574,891 · 17
By mechanism
R01$11,731,884 · 9
R21$1,201,377 · 3
P50$695,165 · 2
S10$599,937 · 1
R41$346,528 · 2
Top collaborators
- Girdhar Gopal Sharma5 shared
- Qin Yang2 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Lynn M Matrisian$19,522,211
- Steven D Hollon$9,788,867
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorIonizing RadiationMalignant NeoplasmsRadiationResponseBinding (Molecular Function)Vascular EndotheliumReceptorRadiation TherapyIrradiationBiologicalCellsDoseMolecular TargetCancer TherapyLibrariesPhage DisplayInhibitor/AntagonistCell SurvivalProteinsPeptidesApoptosisSignal TransductionSignal Pathway
Grant awards (59)
DEVELOP A NOVEL REPROGRAMMING APPROACH FOR GLIOBLASTOMA MULTIFORME TREATMENT$333,594
R01 · FY2019 · NS
DEVELOP A NOVEL REPROGRAMMING APPROACH FOR GLIOBLASTOMA MULTIFORME TREATMENT$333,594
R01 · FY2018 · NS
THE ROLE OF PROTEIN PHOSPHATASE PP2A IN RADIATION INDUCED STEM CELL APOPTOSIS$455,281
R01 · FY2017 · CA · contact PI
THE ROLE OF PROTEIN PHOSPHATASE PP2A IN RADIATION INDUCED STEM CELL APOPTOSIS$455,281
R01 · FY2016 · CA · contact PI
PURCHASE OF AN IMAGE-GUIDED SMALL-ANIMAL IRRADIATOR$599,937
S10 · FY2015 · OD · contact PI
THE ROLE OF PROTEIN PHOSPHATASE PP2A IN RADIATION INDUCED STEM CELL APOPTOSIS$455,281
R01 · FY2015 · CA · contact PI
THE ROLE OF PROTEIN PHOSPHATASE PP2A IN RADIATION INDUCED STEM CELL APOPTOSIS$441,622
R01 · FY2014 · CA · contact PI
Lysophospholipids in Radiation Induced Signal Transduction in Malignant Gliomas$296,760
R01 · FY2014 · CA · contact PI
Tiptuximab Immunotherapeutic for Cancer$225,000
R41 · FY2014 · CA · contact PI
THE ROLE OF PROTEIN PHOSPHATASE PP2A IN RADIATION INDUCED STEM CELL APOPTOSIS$455,281
R01 · FY2013 · CA · contact PI
Lysophospholipids in Radiation Induced Signal Transduction in Malignant Gliomas$287,582
R01 · FY2013 · CA · contact PI
Lysophospholipids in Radiation Induced Signal Transduction in Malignant Gliomas$83,153
R01 · FY2013 · CA · contact PI
Lysophospholipids in Radiation Induced Signal Transduction in Malignant Gliomas$305,938
R01 · FY2012 · CA · contact PI
IMAGE GUIDED IMMUNO THERAPY FOR INDUCIBLE ANTIGENS$200,032
R21 · FY2012 · CA · contact PI
Noninvasive Assessment of Cancer Responsiveness to Therapy by use of .....$123,822
P50 · FY2012 · CA · contact PI
Lysophospholipids in Radiation Induced Signal Transduction in Malignant Gliomas$63,404
R01 · FY2012 · CA · contact PI
Lysophospholipids in Radiation Induced Signal Transduction in Malignant Gliomas$305,938
R01 · FY2011 · CA · contact PI
X-ray Targeted Therapeutic Genes within Nanoparticles$302,750
R01 · FY2011 · CA · contact PI
Noninvasive Assessment of Cancer Responsiveness to Therapy by use of .....$136,648
P50 · FY2011 · CA · contact PI
Lysophospholipids in Radiation Induced Signal Transduction in Malignant Gliomas$315,400
R01 · FY2010 · CA · contact PI
X-ray Targeted Therapeutic Genes within Nanoparticles$308,920
R01 · FY2010 · CA · contact PI
Noninvasive Assessment of Cancer Responsiveness to Therapy by use of .....$167,226
P50 · FY2010 · CA · contact PI
X-ray Targeted Therapeutic Genes within Nanoparticles$320,505
R01 · FY2009 · CA · contact PI
Pharmacodynamic Assessment of RTK Inhibitors in Cancer$186,770
R01 · FY2009 · CA · contact PI
Noninvasive Assessment of Cancer Responsiveness to Therapy by use of .....$163,107
P50 · FY2009 · CA · contact PI
Nanoparticles Targeting Pancreatic Cancer$139,840
R21 · FY2009 · CA · contact PI
Radioprotection by use of Topical Lithium Formulations$121,528
R41 · FY2009 · CA · contact PI
Pharmacodynamic Assessment of RTK Inhibitors in Cancer$71,937
R01 · FY2009 · CA · contact PI
X-ray Targeted Therapeutic Genes within Nanoparticles$46,580
R01 · FY2009 · CA · contact PI
X-ray Targeted Therapeutic Genes within Nanoparticles$362,375
R01 · FY2008 · CA · contact PI
FLK1 Signaling Protects Tumor Vasculature from Radiation$289,930
R01 · FY2008 · CA · contact PI
Pharmacodynamic Assessment of RTK Inhibitors in Cancer$258,707
R01 · FY2008 · CA · contact PI
Nanoparticles Targeting Pancreatic Cancer$141,220
R21 · FY2008 · CA · contact PI
Noninvasive Assessment of Cancer Responsiveness to Therapy by use of .....$104,362
P50 · FY2008 · CA · contact PI
X-ray Targeted Therapeutic Genes within Nanoparticles$364,320
R01 · FY2007 · CA · contact PI
FLK1 Signaling Protects Tumor Vasculature from Radiation$289,930
R01 · FY2007 · CA · contact PI
Pharmacodynamic Assessment of RTK Inhibitors in Cancer$258,357
R01 · FY2007 · CA · contact PI
Nanoparticles Targeting Pancreatic Cancer$141,220
R21 · FY2007 · CA · contact PI
FLK1 Signaling Protects Tumor Vasculature from Radiation$298,589
R01 · FY2006 · CA · contact PI
Pharmacodynamic Assessment of RTK Inhibitors in Cancer$264,843
R01 · FY2006 · CA · contact PI
FLK1 Signaling Protects Tumor Vasculature from Radiation$305,775
R01 · FY2005 · CA
Pharmacodynamic Assessment of RTK Inhibitors in Cancer$269,439
R01 · FY2005 · CA
FLK1 Signaling Protects Tumor Vasculature from Radiation$305,775
R01 · FY2004 · CA
X-Ray Guided Drug Delivery Systems$251,038
R01 · FY2004 · CA
FLK1 SIGNALING PROTECTS TUMOR VASCULATURE FROM RADIATION$255,190
R01 · FY2003 · CA
X-Ray Guided Drug Delivery Systems$251,038
R01 · FY2003 · CA
X-RAYS INDUCE EXOCYTOSIS OF ENDOTHELIAL P-SELECTIN$268,665
R01 · FY2002 · CA
FLK1 SIGNALING PROTECTS TUMOR VASCULATURE FROM RADIATION$255,542
R01 · FY2002 · CA
X-Ray Guided Drug Delivery Systems$251,107
R01 · FY2002 · CA
RECEPTOR TYROSINE KINASE INHIBITION AND RADIATION$0
P50 · FY2002 · CA
X RAY GUIDED DRUG DELIVERY SYSTEMS BY APCITIDE$289,427
R21 · FY2001 · CA
X-RAYS INDUCE EXOCYTOSIS OF ENDOTHELIAL P-SELECTIN$262,300
R01 · FY2001 · CA
FLK1 SINALING PROTECTS TUMOR VASCULATURE FROM RADIATION$256,035
R01 · FY2001 · CA
CELL ADHESION MOLECULE INDUCTION BY IONIZING RADIATION$167,449
R01 · FY2001 · CA
RECEPTOR TYROSINE KINASE INHIBITION AND RADIATION$0
P50 · FY2001 · CA
RECEPTOR TYROSINE KINASE INHIBITION AND RADIATION$0
P50 · FY2001 · CA
X RAY GUIDED DRUG DELIVERY SYSTEMS BY APCITIDE$289,638
R21 · FY2000 · CA
X-RAYS INDUCE EXOCYTOSIS OF ENDOTHELIAL P-SELECTIN$256,126
R01 · FY2000 · CA
CELL ADHESION MOLECULE INDUCTION BY IONIZING RADIATION$163,783
R01 · FY2000 · CA